These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12069831)

  • 1. Lysophospholipids and the cardiovascular system.
    Karliner JS
    Biochim Biophys Acta; 2002 May; 1582(1-3):216-21. PubMed ID: 12069831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.
    Siess W
    Biochim Biophys Acta; 2002 May; 1582(1-3):204-15. PubMed ID: 12069830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of cardioprotection by lysophospholipids.
    Karliner JS
    J Cell Biochem; 2004 Aug; 92(6):1095-103. PubMed ID: 15258895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancer.
    Peyruchaud O
    Anticancer Agents Med Chem; 2009 May; 9(4):381-91. PubMed ID: 19442039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophospholipids in coronary artery and chronic ischemic heart disease.
    Abdel-Latif A; Heron PM; Morris AJ; Smyth SS
    Curr Opin Lipidol; 2015 Oct; 26(5):432-7. PubMed ID: 26270808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities.
    Takuwa Y; Takuwa N; Sugimoto N
    J Biochem; 2002 Jun; 131(6):767-71. PubMed ID: 12038970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of blood and vascular cell function by bioactive lysophospholipids.
    Morris AJ; Panchatcharam M; Cheng HY; Federico L; Fulkerson Z; Selim S; Miriyala S; Escalante-Alcalde D; Smyth SS
    J Thromb Haemost; 2009 Jul; 7 Suppl 1(Suppl 1):38-43. PubMed ID: 19630765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of sphingosine 1-phosphate and lysophosphatidic acid on endothelial cells.
    Panetti TS
    Biochim Biophys Acta; 2002 May; 1582(1-3):190-6. PubMed ID: 12069828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological and pathological actions of sphingosine 1-phosphate.
    Hla T
    Semin Cell Dev Biol; 2004 Oct; 15(5):513-20. PubMed ID: 15271296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of sphingosin-1-phosphate in cardiovascular regulation.
    Li N; Zhang F
    Front Biosci (Landmark Ed); 2016 Jun; 21(7):1296-313. PubMed ID: 27100508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Of spiders and crabs: the emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer.
    Murph M; Tanaka T; Liu S; Mills GB
    Clin Cancer Res; 2006 Nov; 12(22):6598-602. PubMed ID: 17121877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological effects of lysophospholipids.
    Rivera R; Chun J
    Rev Physiol Biochem Pharmacol; 2008; 160():25-46. PubMed ID: 18481029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting sphingosine-1-phosphate signalling for cardioprotection.
    Kennedy S; Kane KA; Pyne NJ; Pyne S
    Curr Opin Pharmacol; 2009 Apr; 9(2):194-201. PubMed ID: 19070545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes.
    Karliner JS; Honbo N; Summers K; Gray MO; Goetzl EJ
    J Mol Cell Cardiol; 2001 Sep; 33(9):1713-7. PubMed ID: 11549349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine-1-phosphate-induced release of TIMP-2 from vascular smooth muscle cells inhibits angiogenesis.
    Mascall KS; Small GR; Gibson G; Nixon GF
    J Cell Sci; 2012 May; 125(Pt 9):2267-75. PubMed ID: 22344262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sphingosine 1-phosphate receptors: from biology to physiopathology].
    Cuvillier O
    Med Sci (Paris); 2012 Nov; 28(11):951-7. PubMed ID: 23171898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis.
    English D; Kovala AT; Welch Z; Harvey KA; Siddiqui RA; Brindley DN; Garcia JG
    J Hematother Stem Cell Res; 1999 Dec; 8(6):627-34. PubMed ID: 10645770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of sphingosine 1-phosphate- and lysophosphatidic acid-induced up-regulation of adhesion molecules and eosinophil chemoattractant in nerve cells.
    Costello RW; Maloney M; Atiyeh M; Gleich G; Walsh MT
    Int J Mol Sci; 2011; 12(5):3237-49. PubMed ID: 21686182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of lysophosphatidic acid in hypertension and atherosclerosis.
    Xu YJ; Aziz OA; Bhugra P; Arneja AS; Mendis MR; Dhalla NS
    Can J Cardiol; 2003 Dec; 19(13):1525-36. PubMed ID: 14760444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases.
    Yatomi Y
    Curr Pharm Des; 2006; 12(5):575-87. PubMed ID: 16472149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.